Orally administrable pharmaceutical pellet of epidermal growth factor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9205130
APP PUB NO 20120308661A1
SERIAL NO

13578211

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention comprises a pellet of epidermal growth factor and methionine or K2S2O7, a capsule which comprises these pellets, processes for theirs preparations and it use for the treatment of ulcerative colitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIAAVE 31 ENTRE 158 Y 190 LA HABANA 10600
BIOREC S ACERRITO 532 OFICINA 802 MONTEVIDEO C P 11 000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aguilera, Barreto Ana San Agustin Lisa, CU 2 2
Martínez, Díaz Eduardo Ciudad de la Habana, CU 4 1
Paez, Meireles Rolando Ciudad de la Habana, CU 3 11
Sereno, Guerra Antonio Melsbroeck, BE 2 3
Ubieta, Gómez Raimundo Ciudad de la Habana, CU 10 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00